Rocky Mountain spotted fever (RMSF) is a life-threatening disease caused by Rickettsia rickettsii, an obligately intracellular bacterium that is spread to human beings by ticks. More than a century after its fi rst clinical description, this disease is still among the most virulent human infections identifi ed, being potentially fatal even in previously healthy young people. The diagnosis of RMSF is based on the patient's history and a physical examination, and often presents a dilemma for clinicians because of the non-specifi c presentation of the disease in its early course. Early empirical treatment is essential to prevent severe complications or a fatal outcome, and treatment should be initiated even in unconfi rmed cases. Because there is no vaccine available against RMSF, avoidance of tick-infested areas is still the best way to prevent the infection.
Introduction
Rocky Mountain spotted fever (RMSF) is a life-threatening disease caused by Rickettsia rickettsii, an obligately intracellular bacterium that is spread to human beings by infected ticks. The disease is the most common tickborne rickettsial disease in the USA and is potentially fatal even in previously healthy young people. [1] [2] [3] RMSF is among the most virulent infections identifi ed in human beings, 4 and its diagnosis often presents a dilemma for clinicians.
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The so-called spotted fever of Idaho: early history
The history of RMSF began in the late 19th century, when Edward E Maxey provided the fi rst clinical description of the so-called spotted fever of Idaho: "a febrile disease, characterized clinically by a continuous moderately high fever, and a profuse or purpuric eruption in the skin, appearing fi rst on ankles, wrists, and forehead, but rapidly spreading to all parts of body". 10 This description became the fi rst report of RMSF to be published in the medical literature. 11 In 1904, Louis B Wilson and William M Chowning studied records of 126 cases of RMSF and concluded that wood ticks (genus Dermacentor) were responsible for transmitting the infection. 12 In 1906, Dermacentor spp ticks were categorically implicated in the transmission of the agent of RMSF, which was unnamed at that time. 13, 14 From 1906 to 1910, Howard T Ricketts isolated the pathogen and showed that it circulated among ticks and mammals in the wild. He also showed that infected ticks could transmit the disease transovarially to their off spring. [14] [15] [16] Tragically, this talented rickettsiologist was aff ected by epidemic typhus and died in 1910, at the age of 39 years. 17 Soon afterward, E R Le Count described the fundamental histopathology fi nding (ie, the vascular lesion) of RMSF. 18 In 1919, S Burt Wolbach published an extensive study on the agent of RMSF, confi rming that ticks carried the bacterium. 19 He also noted the intracellular nature of the pathogen, which principally infected endothelial cells. Wolbach named the agent of RMSF as Dermacentroxenus rickettsii in honour of Howard T Ricketts. The use of the generic term Dermacentroxenus derived from the generic name of the tick vector, Dermacentor andersoni. However, the genus Dermacentroxenus was not universally accepted, and then rapidly unifi ed with the genus Rickettsia, previously used for Rickettsia prowazekii, the causative agent of epidemic typhus. On this basis, the name R rickettsii was proposed in 1922 by Brumpt. 20 Before the discovery of tetracycline and chloramphenicol in the late 1940s, there was no specifi c treatment for RMSF. 21 Only modest success was achieved in treating RMSF with para-aminobenzoic acid and with rabbit hyperimmune serum. 22, 23 At that time, up to 87% of those aff ected did not survive.
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The pathogen R rickettsii (panel 1) is a fastidious, small (0·2-0·5 µm by 0·3-2·0 µm), pleomorphic Gram-negative coccobacillus. The cell-wall composition and lipopolysaccharide of the pathogen resemble that seen in other Gram-negative bacteria. [24] [25] [26] Most cell-surface antigens are recognised by antibodies present in sera of human beings and animals with active RMSF.
26-28 R rickettsii possesses two major immunodominant surface proteins of 190 kDa and 135 kDa: outer membrane protein A (OmpA) and outer membrane protein B (OmpB), respectively. OmpB is the most abundant surface protein of rickettsiae. OmpA and OmpB contain species-specifi c epitopes that provide the basis for rickettsial serotyping by use of comparative indirect microimmunofl uorescence assays. 17 As with other rickettsiae, R rickettsii retains basic fuchsin when stained using the Gimenez method, 29 and its cultivation in the laboratory requires the use of living host cells (animal models, embryonated eggs) or cell cultures (Vero, L929, human embryonic lung, MRC5 cells). 30, 31 R rickettsii typically infects vascular endothelial cells. [32] [33] [34] Unlike other intracellular bacteria that may cause disease in human beings (eg, Ehrlichia spp), R rickettsii is not surrounded by a host cell membrane and can be found in the nucleus or in the cytoplasm of the host cell.
Review
Genomes of various Rickettsia spp have been sequenced previously. [35] [36] [37] Data from rickettsiae genomics are likely to improve the current understanding of the mechanism of rickettsial pathogenicity, 38 and may help the development of new diagnostic tools and vaccines. 17 The unpublished complete genome sequence of R rickettsii (size 1 257 710 bp) has recently been deposited in GenBank (accession number AADJ01000001). The complete genomes of fi ve Rickettsia spp (R bellii, R conorii, R felis, R prowazekii, and R typhi) and the unfi nished genomes of another six (R africae, R akari, R canadensis, R massiliae, R sibirica, and R slovaca) are also available in the GenBank database.
Natural reservoir hosts and mode of transmission
Natural reservoirs of R rickettsii include hard ticks (family Ixodidae; fi gure 1) of various genera and species. 39 The pathogen is maintained in nature, across several tick generations, through transovarial passage (from an infected female tick to her progeny) and transstadial passage (between developmental life stages). Although R rickettsii can also be found in domestic (eg, dogs) and wild mammals, the role of these animals as reservoirs of infection is not well understood. 17, [39] [40] [41] [42] [43] Some of these animals may serve as secondary reservoirs or amplifying hosts. 44 The American dog tick (Dermacentor variabilis; fi gure 2), is the primary vector of R rickettsii in most of the USA. The Rocky Mountain wood tick (D andersoni) is a major vector in the Rocky Mountain region and Canada. The brown dog tick (Rhipicephalus sanguineus; fi gure 3), thought to be the primary vector of R rickettsii in Mexico, 45 has recently been implicated in the transmission of the pathogen in eastern Arizona. 46 Although the role of Rh sanguineus as a vector of R rickettsii has been determined in the laboratory, 47 it has a low affi nity for human beings. 31 However, human parasitism by Rh sanguineus may be more common than previously recognised, 48 and this tick may eventually act as a vector of R rickettsii in other areas where the infection is endemic. 17 The Cayenne tick (Amblyomma cajennense), which is thought to be a common vector of R rickettsii in Central and South America, 9 has a high affi nity for human beings, 31 and has been found naturally infected with R rickettsii in Panama and Brazil. [49] [50] [51] The tick Amblyomma aureolatum, commonly known in Brazil as carrapatoamarelo-do-cão (the yellow dog tick), has recently been implicated as a vector for R rickettsii in Brazil. 52 Other tick species are suspected to be involved in the transmission of R rickettsii. [53] [54] [55] However, some of these tick species seldom bite human beings. Most of the reports on natural infection of ticks with rickettsial agents are based on techniques that are not able to distinguish the Rickettsia species involved. These techniques, particularly the haemolymph test, were (and are still) widely used because of their low cost and simplicity. When assessing the role of a given tick species as a vector of R rickettsii, the presence of confounding organisms (eg, R felis, R bellii, R amblyommii, R parkeri, R prowazekii, and R massiliae) [56] [57] [58] [59] [60] [61] should not be ignored. Thus, the use of techniques (eg, PCR amplifi cation and sequencing) that could accurately identify the Rickettsia spp involved is highly desirable.
R rickettsii is transmitted by the bite of an infected tick, which acts as both reservoir and vector of the pathogen. When the tick is attached to and feeding on a human being, a reactivation phenomenon takes place and R rickettsii transforms from a dormant, avirulent state to a highly pathogenic one. This process requires a minimum period of attachment that often ranges from 4 h to 6 h, although it may be as long as 24 h. 11, 62, 63 There is also a possibility of acquiring R rickettsii infection by contact with tick tissues or fl uids, by inhalation of contaminated aerosol (reported only in laboratories), 64 or through blood transfusion. 65 Particular care needs to be taken when removing ticks to avoid contact with tick tissues or fl uids.
Epidemiology
The geographical distribution of RMSF is restricted to countries of the western hemisphere (fi gure 4). The disease has been found in the USA, western Canada, 66 western and central Mexico, 67, 68 Panama, 69 Costa Rica, 70 northwestern Argentina, 71 Brazil (states of São Paulo, Minas Gerais, Rio de Janeiro, Espírito Santo, Bahia, and Santa Catarina), 51 and Colombia. 72 In the USA, RMSF occurs in all contiguous 48 states, except for Vermont and Maine; 73, 74 half of the cases are found in Oklahoma, Tennessee, and Arkansas, Between 1873 and 1920, 431 cases of RMSF were described in the USA. 75 Between 1997 and 2002, the average annual incidence of the disease was 2·2 cases per million people. 9 Historically, approximately 250-1200 cases of RMSF have been reported annually in the USA, although it is likely that many more cases go unreported. 76, 77 Cyclic fl uctuations of the incidence of RMSF have been observed through the decades. 78 Of note, the number of RMSF cases reported in the USA in 2004, 2005, and 2006 were 1713, 79 1936, 80 and 2092, 81 respectively (each of these numbers represents the highest number of cases ever previously reported). The highest incidence has been observed in children aged less than 10 years (peak age-group, 5-9 years), 74, 78 and among adults aged 40-64 years. 80 The incidence is also high among men and white people. 82, 83 Between 1983 and 1998, fi ve to 39 deaths caused by RMSF were reported annually in the USA, and it has been estimated that some 400 additional deaths were not reported during the same period. 84 In the past, the disease would kill up to 87% of those infected. 12 Today, a fatal outcome has been reported in up to 20% of untreated cases and 5% of treated cases. 9 Geographical variations in case fatality of RMSF are known to occur in the USA. 75 Diff erent isolates of R rickettsii show diff erent levels of pathogenicity in endothelial cell culture; 85 this might explain, in part, the variation in disease severity across distinct geographical regions. In other countries, the case fatality of RMSF can be even higher, as has been reported in Brazil (fi gure 5), where the average case fatality during 1995-2004 was 29·1%. 86 Fatal outcome is associated with older patients (over 60 years), with a greater than 5-day interval between disease onset and treatment, with a lack of tetracycline treatment, or with chloramphenicol-only treatment. 74, 83, 87 Fulminant RMSF in African-American men with glucose-6-phosphate dehydrogenase defi ciency has been reported. 88 In the USA, most cases of RMSF (90-93%) occur between April and September when the tick vectors are most active. 17, 83 RMSF cases are usually found in rural areas, 4, 17, 89 although autochthonous cases have also been reported in urban settings, 78 such as New York. 90 Residence in wooded areas or in areas with high grass and exposure to dogs increases the risk of R rickettsii infection. [91] [92] [93] [94] The disease is sporadic and is clustered in limited geographical regions. By contrast with what occurs in certain endemic areas (eg, Brazil), most cases of RMSF in the USA occur as widely spread single patients and the disease is seldom reported in clusters; only 4·4% of the cases are familial clusters.
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Clinical manifestations
Patients with RMSF display a diverse range of systemic, cutaneous, cardiac, pulmonary, gastrointestinal, renal, neurological, ocular, and skeletal muscle manifestations. 30 Most patients have moderate or severe illness, 30 ,32 and a Review substantial proportion of them need to be admitted to hospital. 83, 93 The mean incubation period of RMSF is 7 days (range 2-14 days). 17, 30, 32, 34, 74 Initial clinical signs and symptoms are similar to those observed in other tickborne rickettsial diseases, making the clinical diagnosis diffi cult in this early phase when treatment would be most eff ective.
During the fi rst 3 days of illness, the classic clinical triad of fever, headache, and rash is observed in only 3% of patients with RMSF. 92 Initially, the disease is characterised by sudden onset of fever (usually greater than 38·9°C), signifi cant malaise, and severe headache (patients often describe the headache as the worst they have ever had), usually accompanied by myalgia, anorexia, nausea, vomiting, abdominal pain, and photophobia. 5, 9, 83, 92, [95] [96] [97] During this phase, RMSF may be misdiagnosed as a viral illness. 98 During the 2 weeks after a tick bite, the classic clinical triad is seen in 60-70% of patients.
11,99,100 A rash appears typically 2-5 days after onset of fever. 17, 32, 34 First, the rash appears as small (1-5 mm diameter), blanching erythematous macules initially on the wrists (fi gure 6) and ankles, with subsequent centrifugal progression to the palms and soles. Then the rash spreads centripetally from the wrists and ankles to the arms (fi gure 7), leg, and trunk. 12, 98 By the end of the fi rst week, the eruption becomes maculopapular with central petechiae. 92, 101 The continuous skin and tissue damage caused by R rickettsii may result in skin necrosis and gangrene, requiring amputation in severe cases.
11,102 However, 9-12% of patients do not break out in a rash. 5, 6, 92, 103, 104 Lack of rash occurs most commonly in cases that are fatal, in older patients, and in African Americans. 32, 91 Other cutaneous manifestations include mucosal ulcers, postinfl ammatory hyperpigmentation, and jaundice. 30, 105 Unlike other tickborne rickettsial diseases, the presence of inoculation eschar is rare in RMSF. 106 Myocarditis is uncommon in patients with RMSF. 92, 107 Pulmonary manifestations such as cough and pneumonia have been reported. 92, 108 Although hepatomegaly is noted at necropsy in almost all fatal cases, this fi nding is noticed in the physical examination of only 12-25% of patients. 92 Acute renal failure is often observed in severe cases. 92, 109 Various neurological manifestations have been reported. 3, 30, 110 Some 40% of patients may develop lethargy, photophobia, meningismus, amnesia, bizarre behaviour suggestive of psychiatric illness, or transient deafness. 92, 94, 111 Ocular manifestations include conjunctivitis (30% of patients), optic disc oedema, arterial occlusion, retinal vein engorgement, retinal haemorrhage, and retinal sheathing. 92, 96, 112, 113 Cases of skeletal muscle involvement with high concentrations of creatine kinase have also been reported.
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Diagnosis: a dilemma for clinicians
The diagnosis of RMSF is based on physical examination of the patient and epidemiological data. However, clinical diagnosis is diffi cult because initial signs and symptoms are often non-specifi c and may lead clinicians to make the wrong diagnosis. 5, 106, [116] [117] [118] [119] [120] [121] [122] [123] Antibodies to R rickettsii are not detectable until 7-10 days after disease onset; 124 thus, serological tests are of limited diagnostic value. 17, 30 A negative result does not exclude the possibility of infection and a positive result does not necessarily confi rm presence of the infection. 17 The WeilFelix test, the oldest serological assay in use, lacks sensitivity and specifi city and is falling into disuse. 11, 17, 125 The indirect fl uorescent antibody test, currently the gold standard of Review serological testing for rickettsioses, 9,104,124 is highly sensitive, but cannot distinguish between infection with R rickettsii and other spotted-fever-group rickettsiae. 17 A four-fold increase of titres in paired samples, or a convalescent titre greater than 1/64, is thought to be diagnostic. 34, 124 ELISA has also been used, 9 and is reputed to be highly sensitive and reproducible. 33 Immunohistochemical staining of rickettsiae antigens in formalin-fi xed, paraffi n-embedded biopsied tissues may be useful during the acute stage of RMSF, particularly in patients with a rash. 9, 126, 127 The immunohistochemical staining of skin biopsy specimens has been reported to be 100% specifi c and 70% sensitive. Although this method has been used to diagnose non-fatal cases of RMSF, it seems to be more useful for detecting rickettsiae in necropsy tissues such as liver, spleen, lung, heart, kidney, and brain. 9, [126] [127] [128] [129] [130] Immunostaining for spotted-fever-group rickettsiae is off ered by the US Centers for Disease Control and Prevention (CDC) and certain US university-based hospitals and commercial laboratories. The use of PCR for the diagnosis of RMSF is limited because of its inferior sensitivity in detecting R rickettsii DNA in blood specimens. 9, 11, [131] [132] [133] The number of rickettsiae circulating in the blood is typically low, particularly in the absence of advanced disease or fulminant infection. 45 This technique seems to be more useful for the detection of R rickettsii in a skin biopsy or necropsy tissue specimen. 55 In acute RMSF, laboratory confi rmation is improved when the PCR is used in association with immunohistochemical staining. 9 New PCR-based methods (eg, quantitative PCR assay) 134 have been developed for the detection and quantifi cation of R rickettsii, and other closely related spotted-fever-group rickettsiae, in diff erent types of samples. These techniques can off er advantages in terms of speed, sensitivity, and reproducibility when compared with conventional PCR.
Because R rickettsii is classifi ed as a biosafety level-3 agent, laboratorial cultivation has not been routinely used for diagnostic purposes. 9, 11 Laboratory fi ndings such as anaemia, thrombocytopenia, raised aminotransferase concentrations, increased bilirubin, increased creatine kinase, and hyponatraemia have been reported in RMSF. 92, 94, 135 The diagnostic use of these fi ndings is limited because they are unspecifi c.
Diff erential diagnosis of RMSF includes an extensive list of tickborne and non-tickborne diseases (panel 2).
Treatment
Because fatal cases of RMSF are often associated with delayed diagnosis, the decision to treat should never be delayed by laboratory confi rmation. 9, 17, 30, 34 Any patient with a fever and rash should be considered for hospital admission and antimicrobial therapy. 136 Tetracyclines and chloramphenicol are the only drugs proven to be eff ective for the treatment of RMSF. 11 Because of its eff ectiveness, broad margin of safety, and convenient dosing schedule, doxycycline is currently considered the drug of choice for nearly all patients, including young children. 7, 9, 88, [137] [138] [139] [140] The current recommended regimens of treatment with doxycycline are 100 mg per dose given twice daily for adults, and 2·2 mg/kg bodyweight per dose given twice daily for children weighing less than 45 kg. 9 These recommended doses may be given orally or intravenously and treatment should be maintained for 5-7 days.
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Doxycycline therapy should be continued until the patient is afebrile for at least 2 or 3 days. 9 Intravenous therapy is often indicated for hospital inpatients, 9 particularly for those with vomiting, unstable vital signs, and neurological symptoms. 104 The use of tetracyclines in the treatment of tickborne rickettsial diseases in children was controversial in the past because the risk of permanent tooth discolouration. 140 Today, there is a consensus that doxycycline is the drug of choice for treating presumptive or confi rmed RMSF in children of any age. 9 A prospective study reported that children treated with doxycycline for RMSF did not show substantial discolouration of permanent teeth compared with those who had never received the drug. 141 Chloramphenicol remains the recommended therapy for RMSF in pregnant women, despite the risk of grey baby syndrome. 9, 32, [142] [143] [144] The indicated dose of chloramphenicol is 50-75 mg/kg per day, divided into four doses, given for 7 days, or until 2 days after the fever has subsided. 142, 143 In life-threatening situations, the use of tetracyclines might be warranted during pregnancy. 9 A study of the knowledge of physicians about the diagnosis and management of RMSF in Mississippi has shown that only 21% of family physicians and 25% of emergency medicine physicians correctly identifi ed doxycycline for treating children with RMSF. 145 Moreover, 23% of physicians reported that waiting for the development of a rash before the treatment decision is an appropriate strategy. 145 This suggests that continuing education is essential to prevent deaths caused by delay of doxycycline therapy. 
Review Prevention
The development of vaccines against rickettsial diseases remains a low priority, as a result of the development of eff ective and safe antibiotics, and mainly because of the decreased perceived threat posed by these diseases. Although some rickettsial pathogens (R rickettsii and R prowazekii) are considered by the CDC to be select agents, there are no vaccines for any rickettsial disease currently approved by the US Food and Drug Administration. 146 Thus, it is essential to emphasise that avoidance of tick-infested habitats (eg, heavily wooded areas) is still the best way to prevent RMSF (panel 3). 34, 143, 147 Sometimes, it is not possible to avoid tick habitats, especially for people who live, work, or enjoy recreational activities in these environments. 148 In these cases, individual protective measures must be adopted. People in contact with tick-infested habitats are advised to wear light-coloured, long-sleeved clothing and footwear, tuck trousers into socks, and bind the exposed edges. The use of permethrin on clothes as an acaricide may also be useful. Removal and decontamination of clothes immediately after leaving tick-infested areas is also suggested. 9, 34, [147] [148] [149] Because the transmission of R rickettsii requires a minimum period of attachment, 11, 62, 63 early tick removal is crucial to diminish the possibility of infection. Frequent physical examination to fi nd and remove attached ticks is recommended. 9, 78, 144, [150] [151] [152] This is particularly important when undergoing activities in tick-infested areas, particularly during tick season (eg, April to September in the USA), when risk of tick exposure increases substantially. The basic recommendations for proper tick removal are shown in panel 4. Punch, shave, or even complete excisional biopsies have been used in some cases when the tick removal is extremely diffi cult or when mouthparts cannot be removed with fi ne forceps. 156 However, experience in successfully removing ticks with ease makes the use of such invasive procedures unnecessary. Moreover, the clinical signifi cance of leaving tick mouthparts embedded in the skin has not been assessed fully, 148 and the risk-tobenefi t ratio of the use of invasive procedures to remove ticks or their mouthparts is unknown.
Chemoprophylaxis should be helpful in certain situations and consists of the use of the tick repellent DEET (N,N-diethyl-meta-toluamide) on the exposed skin. 34 Prophylactic antibiotic administration after a tick bite is not indicated to prevent RMSF. 11 Experimental animal models of R rickettsii infection have shown that the illness was not prevented, but only delayed. 78 
Conclusions
Over a century has elapsed since the fi rst clinical description of RMSF. Despite this, the disease remains among the most severe vector-borne diseases recognised to date, and many aspects of its natural history are still unknown. The diagnosis of RMSF remains a dilemma for clinicians because the diagnostic value of current tools is very limited, particularly during the early course of the illness. Better serological methods to detect specifi c antibodies to R rickettsii in the early phase of infection are needed. A better understanding of the mechanisms involved in the interaction between R rickettsii and the host immune system would help the development of an eff ective vaccine against RMSF; however, many question whether it is really a priority to develop a vaccine for such sporadic (but persistent) and treatable disease. Given that RMSF is one of the oldest and most virulent vector-borne diseases known, which is still killing many of its victims, the answer should be "yes".
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